Systemic Resistance, in the context of hormonal health, refers to the diminished sensitivity of target tissues throughout the body to the signaling action of key hormones, despite adequate or even high circulating levels of those hormones. This phenomenon is a hallmark of metabolic dysfunction, most notably seen as insulin resistance, but also applies to resistance to thyroid hormones, leptin, or androgens. This reduced cellular response compromises metabolic efficiency and homeostatic regulation, contributing to chronic disease states.
Origin
The term is derived from clinical pathology and endocrinology, where “Systemic” indicates the widespread, body-wide nature of the condition, and “Resistance” describes the cellular failure to respond to a chemical messenger. The concept is deeply rooted in the understanding of Type 2 Diabetes Mellitus, where insulin resistance is the central pathophysiological feature. It is a critical descriptor of impaired hormone-receptor signaling.
Mechanism
The molecular mechanism involves post-receptor defects, such as chronic phosphorylation of the receptor’s intracellular domain or the depletion of downstream signaling molecules. In the case of insulin resistance, chronic over-nutrition leads to persistent
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.